Neuro Ultra

This formulation is only released in set batch quantities and requires a 100-unit minimum order. This minimum is fixed for all buyers.

Existing research has found the following:

Supports Cognitive Function Research – Examined for its potential to influence memory, focus, and synaptic communication.
Explores Neuroplasticity & Growth Pathways – Studied for its role in promoting neuronal adaptability and growth factor expression.
Evaluates Mitochondrial & Cellular Resilience – Investigated for its effects on cellular energy metabolism and oxidative stress defense.

Description

Mitochondrial Power Systems

Nicotinamide adenine dinucleotide (NAD⁺) is extensively studied in cell models for its central role in redox cycling, electron transport, and energy transfer within mitochondrial networks.

Neuroplasticity Signaling

Brain-derived neurotrophic factor (BDNF) is a well-characterized protein investigated in neuronal cultures for its influence on synaptic density, neurogenesis, and plasticity-related pathways.

Peptidergic Modulators

Synthetic peptides such as SEMAX and SELANK have been evaluated in pre-clinical assays for their regulatory effects on stress-response mediators and neuronal signaling molecules in non-human systems.

Synaptogenic Investigations

DIHEXA, a small-molecule derivative under in-vitro study, has been explored for its interaction with hepatocyte growth factor (HGF) signaling and associated impacts on synaptic formation in cell models.

Choline Pathway Research

Alpha-GPC (L-alpha-glycerylphosphorylcholine) is used experimentally as a high-yield choline donor in research examining acetylcholine synthesis and phospholipid metabolism.

Acetylcholinesterase Inhibition Models

Huperzine A is widely referenced in enzymology research as a potent, reversible inhibitor of acetylcholinesterase, providing a standard reference for sustained acetylcholine signaling in assay conditions.

Synergistic Network Exploration

Combinatorial studies involving NAD⁺, BDNF, SEMAX, SELANK, DIHEXA, Alpha-GPC, and Huperzine A are ongoing in non-clinical systems to assess potential interactions among neuro-metabolic, redox, and synaptogenic pathways. Observations are model-dependent and not validated for clinical outcomes.

STORAGE DETAILS:
Store sealed at 4 °C (39 °F), protected from light and moisture. Do not freeze. Keep tightly capped to preserve stability and potency.

Application:
An advanced multi-compound nootropic formula under investigation for its synergistic effects on cellular energy metabolism, neuroplasticity, and cognitive signaling pathways. Research explores potential roles in supporting neuronal growth factors, cholinergic transmission, and mitochondrial resilience.

Appearance:
Clear, ready-to-use liquid solution in amber glass dropper bottle.

Molecular Data (Key Active Components)

Compound	Chemical Formula	CAS Number	Approx. Molecular Weight
NAD⁺	C₂₁H₂₇N₇O₁₄P₂	53-84-9	663.4 g/mol
BDNF	Protein (human recombinant)	246791-80-8	~27 kDa
Semax	C₃₇H₅₁N₉O₁₀S	80714-61-0	751.9 g/mol
Selank	C₃₃H₅₇N₁₁O₉	129954-34-3	751.9 g/mol
Dihexa	C₄₄H₆₃N₇O₅	1401708-83-4	753.0 g/mol
Alpha-GPC	C₈H₂₀NO₆P	28319-77-9	257.2 g/mol
Huperzine A	C₁₅H₁₈N₂O	102518-79-6	242.3 g/mol

Synonyms:
Nicotinamide adenine dinucleotide (NAD⁺); Brain-Derived Neurotrophic Factor (BDNF); Heptapeptide Semax; Heptapeptide Selank; N-Hexanoic-Tyrosyl-Ile-(Dihexa); L-alpha-Glycerylphosphorylcholine (Alpha-GPC); HupA.

Concentration:
≥98 % purity for each constituent (by HPLC) as supplied by manufacturer.

Research Use Only (RUO). Not for human or animal use. Not for diagnostic or therapeutic purposes. No claims are made regarding clinical efficacy or cognitive enhancement. End-user assumes responsibility for determining suitability for specific assays.